Is Anticancer Vaccine Possible: Experimental Application of Produced mRNA Transfected Dendritic Cells Derived from Enriched CD34+ Blood Progenitor Cells
None
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2012
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/39810 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Is Anticancer Vaccine Possible: Experimental Application of Produced mRNA Transfected Dendritic Cells Derived from Enriched CD34+ Blood Progenitor Cells
- Major Role for CD8+T Cells in the Protection Against Toxoplasma gondii Following Dendritic Cell Vaccination
- Targeted Cancer Therapy by Dendritic Cell Vaccine
- Dendritic Cell-Based Glioblastoma Vaccines: Advances and Challenges
- Dendritic Cells Interactions with the Immune System – Implications for Vaccine Development
- mRNA2vec: mRNA Embedding with Language Model in the 5'UTR-CDS for mRNA Design
- Equi-mRNA: Protein Translation Equivariant Encoding for mRNA Language Models